CN104906269A - Oral liquid for treating gall-stone - Google Patents

Oral liquid for treating gall-stone Download PDF

Info

Publication number
CN104906269A
CN104906269A CN201510366152.8A CN201510366152A CN104906269A CN 104906269 A CN104906269 A CN 104906269A CN 201510366152 A CN201510366152 A CN 201510366152A CN 104906269 A CN104906269 A CN 104906269A
Authority
CN
China
Prior art keywords
parts
oral liquid
cholelithiasis
treatment
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510366152.8A
Other languages
Chinese (zh)
Inventor
徐国华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510366152.8A priority Critical patent/CN104906269A/en
Publication of CN104906269A publication Critical patent/CN104906269A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of traditional Chinese medicines, in particular provides an oral liquid for treating gall-stone, and aims to achieve the purpose of treating gall-stone by clearing heat and secreting galas well as soothing the liver and circulating qi. To achieve the purpose, the oral liquid is prepared from the following raw materials as active components: 20 parts of drymoglossum piloselloides, 18 parts of japanese violet herb or root, 6 parts of radix bupleuri, 10 parts of bitter oranges, 12 parts of radix paeoniae alba, 25 parts of lysimachia christinae, 15 parts of dandelion, 15 parts of giant knot weed, 9 parts of chicken's gizzard-membranes, 12 parts of honeysuckle, 10 parts of scutellaria baicalensis, 12 parts of pyrrosia lingua, 10 parts of lygodium japonicum, 9 parts of rheum officinale and 3 parts of liquorice. A corresponding preparation method is also adopted. The oral liquid has the effect of treating gall-stone.

Description

A kind of oral liquid being used for the treatment of cholelithiasis
Technical field
The present invention relates to technical field of traditional Chinese medicine preparation, be specifically related to a kind of be used for the treatment of cholelithiasis oral liquid and method for making and application.
Background technology
Cholelithiasis refers to the disease caused by calculus occurred in gallbladder, is a kind of commonly encountered diseases.Increase with the age, sickness rate also raises gradually, and women is obviously more than male.The origin cause of formation of cholelithiasis is very complicated, and some is not modifiable factor, such as: the age increased gradually, women, race, gene and family history; Some is acquired disposition, part can reverse, such as: gestation, obesity, low fiber, high calorie dietary structure, long-time fasting, therefore the medicine finding with Chinese herbal medicine the treatment cholelithiasis being primary raw material has caused the close attention of numerous scientific and technical personnel, and Chinese medicine cholelithiasis has also become a current important topic.
Summary of the invention
Goal of the invention: in order to solve the problem, the object of the present invention is to provide a kind of be used for the treatment of cholelithiasis oral liquid and method for making and application.
Technical scheme: the object of the invention is by following scheme realize:
Be used for the treatment of an oral liquid for cholelithiasis, the active component contained by it is prepared from by following raw materials in part by weight proportioning: Drymoglossum Herba Drymoglossi 20 parts, Herba Violae japonicae 18 parts, Radix Bupleuri 6 parts, Fructus Aurantii 10 parts, the Radix Paeoniae Alba 12 parts, Herba Lysimachiae 25 parts, Herba Taraxaci 15 parts, Rhizoma Polygoni Cuspidati 15 parts, Endothelium Corneum Gigeriae Galli 9 parts, Flos Lonicerae 12 parts, Radix Scutellariae 10 parts, Folium Pyrrosiae 12 parts, Spora Lygodii 10 parts, Radix Et Rhizoma Rhei 9 parts, 3 parts, Radix Glycyrrhizae.
The described oral liquid being used for the treatment of cholelithiasis, preparation method comprises the steps: that getting above-mentioned medical material merges, and decocts with water twice, collecting decoction, when being concentrated into 65 DEG C, relative density is 1.10-1.20, adds ethanol and makes the percent by volume of alcohol content reach 65-85%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.20-1.30 and reclaims ethanol, obtains extractum, add suitable amount of sucrose and water, make oral liquid.
The described oral liquid being used for the treatment of cholelithiasis, in preparation method, decocting condition is: first time adds water as the 8-12 times amount of medical material weight, decocts 1-2h, and second time adds water as the 6-10 times amount of medical material weight, decocts 1-2h.
The described oral liquid being used for the treatment of cholelithiasis, in preparation method, spray drying condition is: inlet temperature is 100-120 DEG C, and leaving air temp is 80-90 DEG C, and temperature of charge is 70-90 DEG C, and atomizing pressure is 0.2-0.4 MPa, and spray velocity is 5-10ml/s.
The application of oral liquid in preparation treatment cholelithiasis medicine of described treatment cholelithiasis.
Drymoglossum Herba Drymoglossi is that Polypodiaceae Drymoglossum Herba Drymoglossi belongs to small-sized Epiphyte, the antipyretic antiinflammatory of energy, wind dispelling cold expelling, clearing away lung-heat to relieve cough and hemostasis.Classification system is Drymoglossum piloselloides (L.) C.Presl, heat-clearing and toxic substances removing, hemostasia and detumescence.For jaundice, tuberculous lymphadenitis, parotitis, hemoptysis of pulmonary tuberculosis, metrorrhagia, breast carcinoma, traumatic injury.The present invention is with all herbal medicine.
Herba Violae japonicae derives from viola inconspicua Blume V.inconspicua Blume, with all herbal medicine.Gather herb when Xia Qiu is bloomed, dry.Meridian distribution of property and flavor: bitter, micro-pungent, cold.Heat-clearing and toxic substances removing, removing heat from blood is subsided a swelling.For acute conjunctivitis, pharyngolaryngitis, acute icterohepatitis, mastitis, carbuncle furuncle and phyma poison, suppurative osteomyelitis, venom.All the other Chinese medicines are pharmacopeia kind.
Beneficial effect: from theory of Chinese medical science, Drymoglossum Herba Drymoglossi, Herba Violae japonicae, Radix Bupleuri, Fructus Aurantii, the Radix Paeoniae Alba, Herba Lysimachiae, Herba Taraxaci, Rhizoma Polygoni Cuspidati, Endothelium Corneum Gigeriae Galli, Flos Lonicerae, Radix Scutellariae, Folium Pyrrosiae, Spora Lygodii, Radix Et Rhizoma Rhei, Radix Glycyrrhizae clearing heat secreting bile in we, soothing the liver circulation of qi promoting, promoting blood circulation and stopping pain effect, is used for the treatment of cholelithiasis.Found by clinical application research, oral liquid of the present invention has well treatment cholelithiasis effect.Formulation of the present invention is reasonable, and compatibility is rigorous.The present invention consists of Chinese crude drug, has no side effect, low price.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
1, embodiment 1: the preparation of oral liquid:
Get Drymoglossum Herba Drymoglossi 20g, Herba Violae japonicae 18g, Radix Bupleuri 6g, Fructus Aurantii 10g, Radix Paeoniae Alba 12g, Herba Lysimachiae 25g, Herba Taraxaci 15g, Rhizoma Polygoni Cuspidati 15g, Endothelium Corneum Gigeriae Galli 9g, Flos Lonicerae 12g, Radix Scutellariae 10g, Folium Pyrrosiae 12g, Spora Lygodii 10g, Radix Et Rhizoma Rhei 9g, Radix Glycyrrhizae 3g medical material also mixes, decoct with water twice, first time adds water as 12 times amount of medical material weight, decoct 2h, second time adds water as 10 times amount of medical material weight, decoct 2h, collecting decoction, filter, filtrate is concentrated into relative density 1.20 (65 DEG C), adding ethanol in proper amount makes alcohol content (volume fraction) reach 85%, stir, leave standstill 24 hours, filter, filtrate recycling ethanol is also concentrated into relative density 1.30 (65 DEG C), obtain extractum, add suitable amount of sucrose and water, make oral liquid.
2. clinical data
2.1 Experimental agents: oral liquid of the present invention, by the preparation of above-described embodiment method, obtain oral liquid 5, specification: 10ml/ props up (being equivalent to containing crude drug 20g).
2.2 dosages: each 1, every day three times.The course for the treatment of: one month be a course for the treatment of, treated for 6 courses for the treatment of altogether.
2.3 are selected in 60 routine cholelithiasis patients altogether, all make a definite diagnosis with B ultrasonic.
2.4 the standard of curative effect evaluations: cure: calculus is got rid of completely, and pain all disappears, and sign is improved completely, happy, in high spirits.Effective: calculus is got rid of substantially, pain disappears, and sign is improved completely, happy, in high spirits.Effective: calculus part is got rid of, and pain disappears substantially, and sign makes moderate progress, mood and spirit are better.Invalid: calculus can not be got rid of, and pain still has, sign and symptom are improved not obvious or without improvement.
In the 2.5 60 routine cases of accepting for medical treatment, through treatment in 5 months, wherein cure 28 examples, effective 16 examples, effective 12 examples, invalid 4 examples, total effective rate reaches 93.3%.

Claims (5)

1. one kind is used for the treatment of the oral liquid of cholelithiasis, it is characterized in that, the active component contained by it is prepared from by following raw materials in part by weight proportioning: Drymoglossum Herba Drymoglossi 20 parts, Herba Violae japonicae 18 parts, Radix Bupleuri 6 parts, Fructus Aurantii 10 parts, the Radix Paeoniae Alba 12 parts, Herba Lysimachiae 25 parts, Herba Taraxaci 15 parts, Rhizoma Polygoni Cuspidati 15 parts, Endothelium Corneum Gigeriae Galli 9 parts, Flos Lonicerae 12 parts, Radix Scutellariae 10 parts, Folium Pyrrosiae 12 parts, Spora Lygodii 10 parts, Radix Et Rhizoma Rhei 9 parts, 3 parts, Radix Glycyrrhizae.
2. be used for the treatment of the oral liquid of cholelithiasis as claimed in claim 1, it is characterized in that preparation method comprises the steps: that getting above-mentioned medical material merges, and decocts with water twice, collecting decoction, when being concentrated into 65 DEG C, relative density is 1.10-1.20, adds ethanol and makes the percent by volume of alcohol content reach 65-85%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.20-1.30 and reclaims ethanol, obtains extractum, add suitable amount of sucrose and water, make oral liquid.
3. be used for the treatment of the oral liquid of cholelithiasis according to claim 2, it is characterized in that, in preparation method, decocting condition is: first time adds water as the 8-12 times amount of medical material weight, decocts 1-2h, and second time adds water as the 6-10 times amount of medical material weight, decocts 1-2h.
4. be used for the treatment of the oral liquid of cholelithiasis according to claim 2, it is characterized in that, in preparation method, spray drying condition is: inlet temperature is 100-120 DEG C, leaving air temp is 80-90 DEG C, temperature of charge is 70-90 DEG C, and atomizing pressure is 0.2-0.4 MPa, and spray velocity is 5-10ml/s.
5. treat the application of oral liquid in treatment cholelithiasis medicine of cholelithiasis as claimed in claim 1.
CN201510366152.8A 2015-06-28 2015-06-28 Oral liquid for treating gall-stone Pending CN104906269A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510366152.8A CN104906269A (en) 2015-06-28 2015-06-28 Oral liquid for treating gall-stone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510366152.8A CN104906269A (en) 2015-06-28 2015-06-28 Oral liquid for treating gall-stone

Publications (1)

Publication Number Publication Date
CN104906269A true CN104906269A (en) 2015-09-16

Family

ID=54075986

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510366152.8A Pending CN104906269A (en) 2015-06-28 2015-06-28 Oral liquid for treating gall-stone

Country Status (1)

Country Link
CN (1) CN104906269A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101274087A (en) * 2008-05-14 2008-10-01 刘庆常 Chinese medicine decoction for invigorating gallbladder and removing gall-stone
CN104162097A (en) * 2014-07-21 2014-11-26 温补来 Traditional Chinese medicine preparation for treating cholelithiasis concurrent with fatty liver
CN104173921A (en) * 2014-08-04 2014-12-03 易爱玲 Traditional Chinese medicine composition as well as preparation and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101274087A (en) * 2008-05-14 2008-10-01 刘庆常 Chinese medicine decoction for invigorating gallbladder and removing gall-stone
CN104162097A (en) * 2014-07-21 2014-11-26 温补来 Traditional Chinese medicine preparation for treating cholelithiasis concurrent with fatty liver
CN104173921A (en) * 2014-08-04 2014-12-03 易爱玲 Traditional Chinese medicine composition as well as preparation and application thereof

Similar Documents

Publication Publication Date Title
CN104491759B (en) A kind of Chinese medicine composition for treating antimigraine and preparation method thereof
CN103041243A (en) Traditional Chinese medicine capsule for clearing heat, expelling noxious substances and removing acnes
CN102512611B (en) Traditional Chinese medicine for treating recurrent oral ulcer and preparation method
CN103550683A (en) Traditional Chinese medicine composition for treating acne
CN100337678C (en) Chinese traditional medicine with hemorrhoid resolving, poison expelling and stagnation expelling functions
CN104547748A (en) Anti-acne drug and preparation method thereof
CN102698202B (en) Chinese medicinal composition for treating gall-stone and preparation method and application of Chinese medicinal composition
CN1582985A (en) Medicine for diabetes and its preparation
CN102716224B (en) Decoction formula for curing rhinitis and preparation method thereof
CN104984312A (en) Traditional Chinese medicine composition for treating gallstones
CN104906269A (en) Oral liquid for treating gall-stone
CN101549140B (en) Traditional Chinese medicine composition for treating AIDS and preparation method thereof
CN105030961A (en) Oculentum for treating eye disease
CN108607055A (en) Treat carcinoid Chinese medicine composition in uterus and preparation method thereof
CN1176708C (en) Capsule for treating psora
CN104645247B (en) A kind of Chinese medicine preparation for treating hepatolenticular degeneration and preparation method thereof
CN103933408A (en) Traditional Chinese medicinal decoction for treating acute gouty arthritis
CN104740405B (en) A kind of Chinese medicine preparation and preparation method for treating anaphylactoid purpura renal damage
CN102258713A (en) Chinese medicinal composition for preventing and treating metabolic diseases
CN101422577A (en) External traditional Chinese medicine for treating scald and burn and preparation method thereof
CN101940720A (en) Traditional Chinese herbal medicine for treating peptic ulcer (blood stasis obstructing the collaterals)
CN104666468A (en) Pharmaceutical composition for treating hyperthyroidism and scrofula
CN105056028A (en) Drug for treatment of chronic prostatitis
CN103977162A (en) Traditional Chinese medicament for treating gestational vulvareczema and preparation method thereof
CN104906455A (en) Pharmaceutical preparation for treating acne

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150916

WD01 Invention patent application deemed withdrawn after publication